Dramatic reduction in the α1D-AR and TRPV1 mRNA levels was observed in PCa specimens (n = 5, pathological staging: pT3b) from patients that had received neoadjuvant androgen deprivation therapy compared with tissues from untreated PCa patients (Figure 2D and E). Here, TRPV1 is linked to posterior cortical atrophy.